Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SHE/002923 stock hub

SHE/002923 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHE/002923is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

4.4B

Shenzhen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHE/002923

In the news

Latest news · SHE/002923

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 17.1P50 24.2P75 37.8

Trailing P/En/a

P25 23.5P50 41.3P75 83.2

ROE-4.7

P25 -0.9P50 4.1P75 8.8

ROIC-2.4

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHE/002923 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

212

Groups with data

Currency

CNY

Showing 212 of 212 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	1,985
Employees Change	40%
Employees Change Percent	2.06
Enterprise value	CNY 4.8B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CNE1000033G8
Last refreshed	2026-05-10
Market cap	CNY 4.4B
Price	CNY 13.24
Price currency	CNY
Rev Per Employee	599,382.22x
Sector	Healthcare
Sic	2834
Symbol	she/002923
Website	https://www.rdpharma.cn

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-1.17%
EV Earnings	-91.86x
EV/EBITDA	39.82x
EV/FCF	67.87x
EV/Sales	4.01x
FCF yield	1.59%
P/B ratio	4.23x
P/S ratio	3.73x
PE Ratio10 Y	50.54x
PE Ratio3 Y	88.75x
PE Ratio5 Y	62.93x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-2.84%
EBITDA Margin	9.85%
FCF margin	5.91%
Gross margin	35.15%
Gross Profit	CNY 418.2M
Gross Profit Growth	-21.45%
Gross Profit Growth Q	17.96%
Gross Profit Growth3 Y	-17.1%
Gross Profit Growth5 Y	-13.14%
Net Income	CNY -52M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-4.33%
Profit Margin	-4.37%
Profit Per Employee	CNY -26,189
ROA	-1
Roa5y	3.97
ROCE	-2.21
ROE	-4.73
Roe5y	9.85
ROIC	-2.36
Roic5y	9.91

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	8.49%
Cagr3y	0.89%
Cagr5y	8.25%
Div CAGR3	-19.33%
Div CAGR5	-7.36%
EPS Growth Quarters	1
EPS Growth Years	0
FCF Growth	-38.49%
FCF Growth Q	-50.91%
OCF Growth	-60.92%
OCF Growth Q	-55.73%
OCF Growth3 Y	12.22%
OCF Growth5 Y	-12.22%
Revenue Growth	-2.76x
Revenue Growth Q	20.2x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	-3.39x
Revenue Growth5 Y	-1.74x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.56
Assets	CNY 2.1B
Cash	CNY 211.5M
Current Assets	CNY 869.6M
Current Liabilities	CNY 543.8M
Debt	CNY 553M
Debt EBITDA	CNY 4.61
Debt Equity	CNY 0.53
Debt FCF	CNY 7.86
Equity	CNY 1B
Interest Coverage	-2.46
Liabilities	CNY 1B
Long Term Assets	CNY 1.2B
Long Term Liabilities	CNY 482.5M
Net Cash	CNY -341.5M
Net Cash By Market Cap	CNY -7.7
Net Debt EBITDA	CNY 2.91
Net Debt Equity	CNY 0.33
Net Debt FCF	CNY 4.85
Tangible Book Value	CNY 983.9M
Tangible Book Value Per Share	CNY 2.94
WACC	4.59

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.6
Inventory Turnover	1.8
Net Working Capital	CNY 329.9M
Quick ratio	0.82
Working Capital	CNY 325.8M
Working Capital Turnover	CNY 3.29

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	2.03%
Dividend Growth	-25%
Dividend Growth Years	0%
Dividend per share	CNY 0.15
Dividend Years	8
Dividend Yield	1.13%
Ex Div Date	2025-05-30
Last Dividend	CNY 0.15
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	8.49%
200-day SMA	13.88
3Y total return	2.7%
50-day SMA	14.59
50-day SMA vs 200-day SMA	50over200
5Y total return	48.65%
All Time High	22.25
All Time High Change	-40.5%
All Time High Date	2021-11-26
All Time Low	6.81
All Time Low Change	94.42%
All Time Low Date	2024-02-08
ATR	0.6
Beta	0.12
Beta1y	-0.2
Beta2y	0.12
Ch YTD	8.97
High	13.31
High52	18.96
High52 Date	2026-04-02
High52ch	-30.17%
Low	12.9
Low52	11.8
Low52 Date	2025-07-15
Low52ch	12.2%
Ma50ch	-9.24%
Price vs 200-day SMA	-4.58%
RSI	46.13
RSI Monthly	51.75
RSI Weekly	46.04
Sharpe ratio	0.28x
Sortino ratio	0.57
Total Return	3.16%
Tr YTD	8.97
Tr1m	-8.82%
Tr1w	-1.56%
Tr3m	-16.57%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY -33.8M
Operating Income Growth Q	137.2
Operating margin	-2.84

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	126,674,642%
Net Borrowing	38,765,474
Shares Insiders	61.09%
Shares Institutions	3.34%
Shares Out	334,893,286
Shares Qo Q	-22.05%
Shares Yo Y	-2.03%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 70.4M
Average Volume	14,632,726.7x
Bv Per Share	3.13
CAPEX	CNY -20.5M
Ch1m	-8.82
Ch1w	-1.56
Ch1y	7.21
Ch3m	-16.57
Ch3y	-2.19
Ch5y	36.3
Ch6m	-0.9
Change	0.91%
Change From Open	1.38
Close	13.12
Days Gap	-0.46
Depreciation Amortization	150,981,788
Dollar Volume	156,367,365.8
Earnings Date	2026-04-28
EBIT	CNY -33.8M
EBITDA	CNY 117.2M
EPS	CNY -0.16
F Score	4
FCF	CNY 70.4M
FCF EV Yield	1.47x
FCF Per Share	CNY 0.21
Financing CF	-83,475,655
Fiscal Year End	December
Founded	1,999
Income Tax	CNY 493,488
Investing CF	-20,296,864
Is Primary Listing	1
Last Earnings Date	2026-04-28
Last Report Date	2025-09-30
Last Split Date	2023-05-31
Last Split Type	Forward
Ma150	13.85
Ma150ch	-4.43%
Ma20	13.01
Ma20ch	1.74%
Net CF	-11,369,671
Next Earnings Date	2026-08-13
Open	13.06
P FCF Ratio	63.02
P OCF Ratio	48.82
Payment Date	2025-05-30
Position In Range	82.93
Ppne	1,115,238,672
Price Date	2026-05-08
Price EBITDA	CNY 37.84
Ptbv Ratio	4.51
Relative Volume	0.82x
Revenue	1,189,773,703x
Tax By Revenue	0.04x
Tr6m	-0.9%
Volume	11,810,224
Z Score	3.4

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHE/002923 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.1%

$0.15 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-7.4%

0 consecutive years of growth

Total shareholder yield

+3.2%

Next ex-dividend date: 2025-05-30

Performance

SHE/002923 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHE/002923?

Insider, institutional, and short-interest positioning.

Institutional ownership

+3.3%

Share of float held by funds and institutions

Insider ownership

+61.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-2.0%

Negative means the company is buying back shares.

Technical

SHE/002923 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

46.1

Neutral momentum band

Price vs 200-day MA

-4.6%

50/200-day relationship not available

Beta (5Y)

0.12

Less volatile than the market

Sharpe ratio

0.28

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHE/002923

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/002923 stock rating?

she/002923 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/002923 analysis?

The full report lives at /stocks/she/002923/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/002923?

The latest report frames she/002923 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/002923 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.